Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Toes

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|September 8, 2005
Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohortJ Wesoly, A H M van der Helm-van Mil, R E Toes, et al.
Arthritis and Rheumatism|July 1, 2009
Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathwaysL A Trouw, E M Haisma, E W N Levarht, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus toleranceA T den Boer, L Diehl, G J van Mierlo, et al.
Biochemical Society Transactions|August 1, 1995
Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escapeR E Toes, M C Feltkamp, M E Ressing, et al.
The Journal of Experimental Medicine|June 6, 2000
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosisH Singh-Jasuja, R E Toes, P Spee, et al.
Clinical and Experimental Immunology|November 9, 2011
The major risk alleles of age-related macular degeneration (AMD) in CFH do not play a major role in rheumatoid arthritis (RA)L A Trouw, S Böhringer, N A Daha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Adoptive T cell immunotherapy of human uveal melanoma targeting gp100R P Sutmuller, L R Schurmans, L M van Duivenvoorde, et al.
The Journal of Experimental Medicine|July 6, 2000
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuliD H Schuurhuis, S Laban, R E Toes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
Rejection of intraocular tumors by CD4(+) T cells without induction of phthisisL R Schurmans, L Diehl, A T den Boer, et al.
The Journal of Experimental Medicine|July 4, 2001
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage productsR E Toes, A K Nussbaum, S Degermann, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|September 8, 2005
Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohortJ Wesoly, A H M van der Helm-van Mil, R E Toes, et al.
Arthritis and Rheumatism|July 1, 2009
Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathwaysL A Trouw, E M Haisma, E W N Levarht, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus toleranceA T den Boer, L Diehl, G J van Mierlo, et al.
Biochemical Society Transactions|August 1, 1995
Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escapeR E Toes, M C Feltkamp, M E Ressing, et al.
The Journal of Experimental Medicine|June 6, 2000
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosisH Singh-Jasuja, R E Toes, P Spee, et al.
Clinical and Experimental Immunology|November 9, 2011
The major risk alleles of age-related macular degeneration (AMD) in CFH do not play a major role in rheumatoid arthritis (RA)L A Trouw, S Böhringer, N A Daha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Adoptive T cell immunotherapy of human uveal melanoma targeting gp100R P Sutmuller, L R Schurmans, L M van Duivenvoorde, et al.
The Journal of Experimental Medicine|July 6, 2000
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuliD H Schuurhuis, S Laban, R E Toes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
Rejection of intraocular tumors by CD4(+) T cells without induction of phthisisL R Schurmans, L Diehl, A T den Boer, et al.
The Journal of Experimental Medicine|July 4, 2001
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage productsR E Toes, A K Nussbaum, S Degermann, et al.
Pageof 6